A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

Recruiting now

Conditions studied: Non-Segmental Vitiligo (NSV), Alopecia Areata, Hidradenitis Suppurativa

In brief

This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.

Key facts

Study ID

NCT07136467

Run by

AbbVie

People needed

2795

Starts

2025-09-02

Expected to finish

2027-08-01

Last updated by the study team

2026-02-13

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants with Physician-confirmed diagnosis of non-segmental vitiligo (NSV), moderate to severe Alopecia Areata (AA), or moderate to severe hidradenitis suppurativa (HS)
• Participants Ability to understand study questionnaires, with caregiver support as required for adolescents

You may not qualify if…

• Participating in interventional clinical trial(s) at time of study visit (participation in another non-interventional study or registry does not exclude a participant from this study)
• Unable or unwilling to comply with study requirements and PRO collection

Where it is running

• Buenos Aires Skin /ID# 277637 — Buenos Aires, Argentina (enrolling)
• Centro de Investigacion y Prevencion Cardiovascular (CIPREC) /ID# 277634 — Buenos Aires, Argentina (enrolling)
• Hospital Italiano de Buenos Aires /ID# 277636 — Buenos Aires, Argentina (enrolling)
• Instituto de Neumonología y Dermatología /ID# 277635 — Buenos Aires, Argentina (enrolling)
• Dermatology Research Institute - Blackfoot Trail /ID# 276548 — Calgary, Alberta, Canada (enrolling)
• Rejuvenation Dermatology - Edmonton Downtown /ID# 276593 — Edmonton, Alberta, Canada (enrolling)
• Alberta Dermatology Consultants /ID# 277187 — Edmonton, Alberta, Canada (enrolling)
• Brunswick Dermatology Center /ID# 276546 — Fredericton, New Brunswick, Canada (enrolling)
• Simcoderm Medical And Surgical Dermatology Centre /ID# 276838 — Barrie, Ontario, Canada (enrolling)
• DermEffects /ID# 276594 — London, Ontario, Canada (enrolling)
• Lynderm Research Inc /ID# 276595 — Markham, Ontario, Canada (enrolling)
• York Dermatology Clinic & Research Centre /ID# 276697 — Richmond Hill, Ontario, Canada (enrolling)
• Dermacentre Recherches /Id# 277593 — Pointe-Claire, Quebec, Canada (enrolling)
• Centro de Inmunología y Genética CIGE SAS /ID# 280793 — Medellín, Antioquia, Colombia (enrolling)
• Policlinico Social Del Norte /ID# 280935 — Bogotá, Bogota D.C., Colombia (enrolling)
• Nemocnice Na Bulovce /ID# 275542 — Prague, Central Bohemia, Czechia (enrolling)
• Dermafit Centrum /ID# 275863 — Pilsen, Plzeň Region, Czechia (enrolling)
• Dermamedest /ID# 275861 — Prague, Praha 2, Czechia (enrolling)
• North Estonia Medical Centre /ID# 276933 — Tallinn, Harju, Estonia (enrolling)
• Tartu University Hospital /ID# 276932 — Tartu, Estonia (enrolling)
• Chu Dijon /Id# 277493 — Dijon, Bourgogne-Franche-Comté, France (enrolling)
• Centre Hospitalier Regional Universitaire de Besancon - Hopital Jean Minjoz /ID# 277459 — Besançon, Doubs, France (enrolling)
• Centre Hospitalier Universitaire de Bordeaux - Groupe Hospitalier Saint-Andre /ID# 277322 — Bordeaux, Gironde, France (enrolling)
• CHU Toulouse - Hopital Larrey /ID# 277321 — Toulouse, Haute-Garonne, France (enrolling)
• Hospital Britanico de Buenos Aires /ID# 278940 — Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.